# Oriental Aromatics share price today (Oriental Aromatics Ltd, NSE: OAL)

> Oriental Aromatics share price today: ₹560.05 at the NSE close on 3 November 2026, up 51.5% in a year. Oriental Aromatics (NSE: OAL) is worth ₹1,886 crore, trades at a P/E of 354.3 and has closed between ₹234.60 and ₹627.90 over the past 52 weeks. > Oriental Aromatics Ltd's share price has risen faster than its earnings: +51.5% in a year, against −90.4% for earnings per share. OAL · Chemicals - Organic · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/oriental-aromatics-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: ₹560.05 (+51.5% in a year)
- P/E: 354.3× (higher than 99% of the last 8.1 years)
- Revenue (Jun 2026): ₹260 Cr (+15.2% on a year ago)
- Profit (Jun 2026): ₹2.5 Cr (+402.0% on a year ago)
- Operating margin: 7.6% (−0.4 points on a year ago)
- ROCE: 4%, FY26
- ROIC: 1.4%, against a 12.0% cost of capital: −10.6 points

The main question: the share price moved +51.5% in a year while yearly earnings per share moved −90.4%. The difference came from the market paying a higher multiple. ## What is the Oriental Aromatics share price today? Oriental Aromatics Ltd's share price was ₹560.05 at the close on 3 November 2026. It has been rising for 20 weeks. That is 38.7% above its average price over the last 200 trading days. In the last 52 weeks it traded between ₹235 and ₹628, and at that close it sat 83% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 12 weeks in a row. Over the last 11 years the share price moved +394% while the NIFTY 500 moved +251%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Oriental Aromatics this quarter? One change stood out: revenue up on a year earlier for 10 quarters in a row. 1. Revenue up on a year earlier for 10 quarters in a row In the June 2026 quarter revenue was ₹260 crore, +15.2% on a year earlier. Why: The company sold more product. Sales and production volumes both rose, helped by better use of its plants and execution. Next results: check whether sales growth stays near the 10% to 15% one-year goal. From the earnings call on 31 Jul 2026. ## What are Oriental Aromatics' latest quarterly results? For April to June 2026 (the quarter ended 30 June 2026), Oriental Aromatics reported revenue of ₹260 crore, up 15.2% from ₹226 crore a year earlier, and a profit of ₹2.51 crore, up 402.0% from ₹0.50 crore. ### Oriental Aromatics results: April to June 2026 against a year earlier

| Measure | April to June 2026 | April to June 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹260 crore | ₹226 crore | +15.2% |
| Profit | ₹2.51 crore | ₹0.50 crore | +402.0% |
| Earnings per share | ₹0.75 | ₹0.15 | +400.0% |
| Operating margin | 7.6% | 8.0% | −0.4 points |

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Oriental Aromatics' management discussed these results on a call held on 31 July 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.)

## What is the Oriental Aromatics share price history? Oriental Aromatics closed at ₹560.05 on 3 November 2026, up 51.5% from ₹369.70 a year earlier (31 October 2025) and down 30.9% over five years. Its highest weekly close since March 2016 was ₹1,021.35 on 17 September 2021. ### Oriental Aromatics share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹575.60 | −2.7% |
| 1 month ago · 1 Oct 2026 | ₹535.95 | +4.5% |
| 6 months ago · 30 Apr 2026 | ₹307.70 | +82.0% |
| 1 year ago · 31 Oct 2025 | ₹369.70 | +51.5% |
| 3 years ago · 3 Nov 2023 | ₹339.00 | +65.2% |
| 5 years ago · 4 Nov 2021 | ₹810.00 | −30.9% |
| 10 years ago · 4 Nov 2016 | ₹174.72 | +220.5% |
| Earliest weekly close in our records · 11 Mar 2016 | ₹113.43 | +393.7% |
| Highest weekly close since March 2016 · 17 Sep 2021 | ₹1,021.35 | −45.2% |
| Lowest weekly close since March 2016 · 1 Apr 2016 | ₹111.90 | +400.5% |
| 52-week high (weekly close) · 16 Oct 2026 | ₹627.90 | −10.8% |
| 52-week low (weekly close) · 27 Mar 2026 | ₹234.60 | +138.7% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (561 weekly closes from 11 March 2016 to 3 November 2026.)

## What is the latest news on Oriental Aromatics? 3 Nov 2026: Oriental Aromatics closed at ₹560.05, down 2.7% on the week and up 4.5% on the month. 5 Aug 2026: ex-date for a dividend of ₹0.50 a share. ### Earlier

- 31 Jul 2026: Oriental Aromatics held its results call for April to June 2026. Management guided: Management set a near-term sales-growth trajectory of 10.0%-15.0% over the next one year. - Results for April to June 2026: Revenue up 15.2% and profit up 402.0% on a year earlier. ## What dividend does Oriental Aromatics pay? Oriental Aromatics paid ₹0.50 a share in regular dividends in the 12 months to 4 November 2026 (1 payment), a yield of 0.09% at the ₹560.05 close on 3 November 2026. The last was a dividend of ₹0.50 a share, ex-date 5 August 2026. ### Oriental Aromatics dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 5 Aug 2026 | ₹0.50 | Dividend | same day |
| 8 Aug 2025 | ₹0.50 | Dividend | same day |
| 6 Aug 2024 | ₹0.50 | Dividend | n/a |
| 3 Aug 2023 | ₹0.50 | Dividend | n/a |
| 9 Dec 2021 | ₹1.50 | Interim | 10 Dec 2021 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 4 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Oriental Aromatics Ltd paid out 51% of its profit as dividends in FY26, and it paid a dividend in each of its last 10 reported years. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Oriental Aromatics management say on the latest results call? On the call for April to June 2026, held on 31 July 2026, Oriental Aromatics' management guided: Management set a near-term sales-growth trajectory of 10.0%-15.0% over the next one year. > “Our immediate priority is therefore to maximize utilization and improve profitability from the existing assets before undertaking any major expansionary investments.”
> Shyamal Bodani, on the call for April to June 2026

### What management guided

- Mahad utilization goal of 75.0%-80.0%, at which management expects operating profit-positive economics and meaningful consolidated contribution. - New-product commercialization generally takes 500-1,000 days from development to commercial business. - FY27 effective tax rate around 25.0%, with liability at the parent and none at the overseas subsidiary. - Export contribution expected to remain in the same broad range, following 35.0% in Q1 versus 33.0% in the previous financial year. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijoristack.ai/concall/transcript/53-31-Jul-2026.pdf). (From the call for April to June 2026, 31 July 2026.)

## What to watch in Oriental Aromatics' next results? When Oriental Aromatics reports July to September 2026, these are the 3 checks that show whether the story is still on course. First: Consolidated operating margin should show further sequential improvement from 7.6% while Alpha-Pinene and other input costs remain elevated; management supplied no explicit margin goal. - What to check (from the call)
- Consolidated operating margin should show further sequential improvement from 7.6% while Alpha-Pinene and other input costs remain elevated; management supplied no explicit margin goal. - Camphor and terpene volume and pricing through seasonally stronger Q2, with Asian overcapacity testing pass-through and profitability. - Revenue growth versus realization: assess whether volume-led momentum can support the 10.0%-15.0% one-year sales trajectory as early customer allocations normalize. ## Which stock lists is Oriental Aromatics on? Oriental Aromatics is on one of our India lists: Momentum stocks. [Momentum stocks Market cap cr: 1981.964517828913](https://www.sectoralpha.in/momentum-stocks-india)

## Is Oriental Aromatics profitable? Oriental Aromatics Ltd earned ₹2.5 Cr of net profit in the Jun 2026 quarter, +402.0% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹3.0 Cr. Over 9 years profit has grown −22.0% a year on average. That is 1.0% of the quarter's revenue. The same quarter a year earlier earned ₹0.5 Cr. 1 of the last 12 reported quarters were loss-making. For the full year, FY26 profit was ₹3.0 Cr (−91.2% on the year before). Why profit moved: revenue changed +15.2% on a year earlier and the margin moved −0.4 percentage points. Sales did the work, and the margin was about flat. On average over the last four quarters, profit changed +90.3% and revenue +13.6%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Oriental Aromatics make, and is it growing? Oriental Aromatics Ltd reported ₹260 Cr of revenue in the Jun 2026 quarter, +15.2% on the same quarter a year earlier. That is the 10th quarter in a row with growth on the year before. Over 9 years it has grown 9.4% a year on average. The last full year, FY26, came in at ₹1,031 Cr. The last four reported quarters add to ₹1,065 Cr. FY26 revenue was ₹1,031 Cr, +11.1% on the year before. Recent pace: the last four quarters grew +13.6% on average, against 9.4% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +13.5%, against +11.5% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −77.7%, against −54.9% a year (rolling over). ## How much of every ₹100 of sales does Oriental Aromatics keep? Oriental Aromatics Ltd's operating margin was 7.6% in the Jun 2026 quarter, 0.4 percentage points lower than the same quarter a year ago. Across 10 years it has been between 6.0% and 22.0%. The latest quarter is within that range. Why the margin moved: operating margin changed −0.4 percentage points on the year while gross margin changed −5.8 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Oriental Aromatics' profit turning into cash? Over the last 3 years, 239% of Oriental Aromatics Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹2.0 Cr of operating cash against ₹3.0 Cr of profit. After ₹11.0 Cr of spending on assets, free cash was −₹9.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 239% of profit came in as cash: the cash cycle stayed about the same between FY21 and FY26, so the cash follows profit, not the cycle. What to look at next: the bigger use of cash is spending on new assets, at 2.9× depreciation over three years. The next section checks what that spending is building. ## Where does Oriental Aromatics' cash go? Oriental Aromatics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 247 days in FY26, up from 242 days in FY21. It spent ₹214 Cr on assets over the last 3 years. Customers take 89 days to pay, and stock sits for 203 days on average. At FY26 sales of ₹1,031 Cr, each day of that cycle ties up about ₹2.8 Cr, so roughly ₹698 Cr is tied up in the business at any time. FY26: customers took 89 days to pay and stock sat for 203 days, about 6.7 months of sales sitting as stock, for a full cycle of 247 days, longer than FY21's 242. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 203 days. Customers pay about 89 days after that. Suppliers are paid at 44 days. Together that makes the 247-day cycle. Spending on assets: ₹214 Cr over the last 3 years, against ₹75.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹5.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Oriental Aromatics' P/E ratio, and how does it compare with its own history? Oriental Aromatics Ltd's P/E is 354.3×, about the highest it has ever been. Its usual P/E (the middle reading) is 34.4×, over 8.1 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −90.4% while the price moved +51.5%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved −7.1% a year; about −43.7% a year came from earnings growth and about +36.6 percentage points from the multiple (the market paying more). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Oriental Aromatics business getting better or worse? Oriental Aromatics Ltd's business is getting worse. Profit and EPS growth are shrinking: profit growth is −77.7% in the latest quarter, against +25205.9% at its best in 12 quarters, with ROCE steady at 6.4%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Oriental Aromatics earn on its capital? Oriental Aromatics Ltd earned a ROCE of 4% in FY26. Its return on capital used (ROIC) is 10.6 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 0.3% net margin and 0.86× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 0.3% net margin × 0.86× asset turnover × 1.80× leverage (assets divided by equity) ≈ 0.5% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 1.4% − 12.0% = −10.6 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Oriental Aromatics have too much debt? Oriental Aromatics Ltd has total debt of ₹403 Cr against shareholder equity of ₹665 Cr as of Jun 2026, so its debt is 0.61× its equity. Year by year, that ratio went from 0.23 in FY22 to 0.61 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Oriental Aromatics shareholding pattern? No group of Oriental Aromatics Ltd's owners changed its stake by a full percentage point over the last two years. Promoters moved +0.0 points over the same period, to 74.2%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Foreign institutions: −0.1 points over 8 quarters, to 0.0%; Promoters: +0.0 points over 8 quarters, to 74.2%; Domestic institutions: +0.0 points over 8 quarters, to 0.0%. ## How far is Oriental Aromatics from balance-sheet trouble? For Oriental Aromatics Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Oriental Aromatics rank in its industry? 36.5 out of 100, rank 16 of 20 in Chemicals - Organic, with 74% of the evidence available. Oriental Aromatics Ltd scores 36.5 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 16. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 11 + 5 + 8 + 12.5 = 36.5. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Oriental Aromatics compared with? Oriental Aromatics ranks 16 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 36.5 out of 100. 1. [Nitta Gelatin India Ltd](https://www.sectoralpha.in/stocks/nitta-gelatin-india-ltd) NITTAGELA · quiet · Most evidence points up · 85% evidence 76.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.4/35 · Revenue 15% · Profit 49.4% · Operating margin change 9 points · 100% evidence Capital efficiency 21.3/25 · ROCE 27.7% · Operating margin 28% · 100% evidence Valuation 13.2/20 · P/E 12.1× · PEG 0.95 · 100% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 35.5% · 1 year n/a · 25% evidence · 5 of 12 weeks ahead Exact sum: 30.4 + 21.3 + 13.2 + 12 = 76.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) INDOAMIN · losing its lead · Most evidence points up · 81% evidence 66.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 13.3% · Profit 24.2% · Operating margin change 3 points · 88% evidence Capital efficiency 16.8/25 · ROCE 18.9% · Operating margin 14% · 100% evidence Valuation 19.0/20 · P/E 10.6× · PEG 0.32 · 100% evidence Relative strength 9.5/20 · Lead over its industry n/a · Lead over NIFTY 500 2.3% · 1 year -10.4% · 25% evidence · 4 of 12 weeks ahead Exact sum: 20.8 + 16.8 + 19 + 9.5 = 66.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) VALIANTORG · breaking out · Evidence leans up · 78% evidence 61.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 1.5% · Profit 100% · Operating margin change 6 points · 83% evidence Capital efficiency 9.0/25 · ROCE 5.5% · Operating margin 18% · 76% evidence Valuation 10.9/20 · P/E 23.2× · PEG n/a · 50% evidence Relative strength 19.8/20 · Lead over its industry 24.1% · Lead over NIFTY 500 48.6% · 1 year 39.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 21.4 + 9 + 10.9 + 19.8 = 61.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [OCCL Ltd](https://www.sectoralpha.in/stocks/occl-ltd) OCCLLTD · breaking out · Too little evidence to rank firmly · 56% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 40.6% · Profit 100% · Operating margin change 7 points · 83% evidence Capital efficiency 12.3/25 · ROCE 13% · Operating margin 28% · 76% evidence Valuation 11.1/20 · P/E 11× · PEG n/a · 15% evidence Relative strength 12.1/20 · Lead over its industry n/a · Lead over NIFTY 500 45.3% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.6 + 12.3 + 11.1 + 12.1 = 59.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [BASF India Ltd](https://www.sectoralpha.in/stocks/basf-india-ltd) BASF · quiet · Evidence leans up · 71% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 6.5% · Profit 62.4% · Operating margin change 4 points · 88% evidence Capital efficiency 11.7/25 · ROCE 14.5% · Operating margin 10% · 100% evidence Valuation 14.1/20 · P/E 21.4× · PEG n/a · 50% evidence Relative strength 7.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -13% · 1 year -30.9% · 25% evidence · 5 of 12 weeks ahead Exact sum: 23.8 + 11.7 + 14.1 + 7.7 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Elantas Beck India Ltd](https://www.sectoralpha.in/stocks/elantas-beck-india-ltd) ELANTAS · leader · Evidence leans up · 67% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 18.7% · Profit 35.5% · Operating margin change 1 points · 95% evidence Capital efficiency 18.1/25 · ROCE 21.2% · Operating margin 23% · 76% evidence Valuation 6.5/20 · P/E 54.1× · PEG n/a · 50% evidence Relative strength 11.8/20 · Lead over its industry n/a · Lead over NIFTY 500 31.9% · 1 year 33.1% · 25% evidence · 12 of 12 weeks ahead Exact sum: 20.7 + 18.1 + 6.5 + 11.8 = 57.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 7. [Fine Organic Industries Ltd](https://www.sectoralpha.in/stocks/fine-organic-industries-ltd) FINEORG · leader · Evidence leans up · 96% evidence 56.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 7.1% · Profit 5.8% · Operating margin change 4 points · 88% evidence Capital efficiency 17.8/25 · ROCE 21.5% · Operating margin 25% · 100% evidence Valuation 15.0/20 · P/E 35.3× · PEG 0.58 · 100% evidence Relative strength 9.9/20 · Lead over its industry -7.6% · Lead over NIFTY 500 12.4% · 1 year 13.8% · 100% evidence · 9 of 12 weeks ahead Exact sum: 13.9 + 17.8 + 15 + 9.9 = 56.6 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) LXCHEM · quiet · Evidence leans up · 81% evidence 54.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 5.5% · Profit 26% · Operating margin change 7.6 points · 88% evidence Capital efficiency 10.8/25 · ROCE 4.7% · Operating margin 12% · 100% evidence Valuation 13.1/20 · P/E 33.8× · PEG 1.14 · 100% evidence Relative strength 9.2/20 · Lead over its industry n/a · Lead over NIFTY 500 1.8% · 1 year -22% · 25% evidence · 10 of 12 weeks ahead Exact sum: 21.1 + 10.8 + 13.1 + 9.2 = 54.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) BALAMINES · quiet · Evidence leans up · 78% evidence 53.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.2/35 · Revenue 11.1% · Profit 41.6% · Operating margin change 10 points · 83% evidence Capital efficiency 13.1/25 · ROCE 11% · Operating margin 25% · 76% evidence Valuation 9.1/20 · P/E 28× · PEG n/a · 50% evidence Relative strength 8.2/20 · Lead over its industry -2.5% · Lead over NIFTY 500 15.2% · 1 year 25.3% · 100% evidence · 6 of 12 weeks ahead Exact sum: 23.2 + 13.1 + 9.1 + 8.2 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Fairchem Organics Ltd](https://www.sectoralpha.in/stocks/fairchem-organics-ltd) FAIRCHEMOR · quiet · Evidence leans up · 100% evidence 53.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.3/35 · Revenue 17.1% · Profit 100% · Operating margin change 6.2 points · 100% evidence Capital efficiency 7.0/25 · ROCE 3.3% · Operating margin 10% · 100% evidence Valuation 13.0/20 · P/E 32.7× · PEG 0.84 · 100% evidence Relative strength 3.0/20 · Lead over its industry -15.4% · Lead over NIFTY 500 3.2% · 1 year -15.9% · 100% evidence · 9 of 12 weeks ahead Exact sum: 30.3 + 7 + 13 + 3 = 53.3 · What this means: Earnings are strong; relative strength in its sector is -15.4% and the one-year return is -15.9%. 11. [Sigachi Industries Ltd](https://www.sectoralpha.in/stocks/sigachi-industries-ltd) SIGACHI · breaking out · Evidence leans down · 100% evidence 49.4 out of 100 Growth Capital Valuation Relative
12. [GFL Ltd](https://www.sectoralpha.in/stocks/gfl-ltd) GFLLIMITED · breaking out · Evidence leans down · 71% evidence 48.6 out of 100 Growth Capital Valuation Relative
13. [Jyoti Resins and Adhesives Ltd](https://www.sectoralpha.in/stocks/jyoti-resins-and-adhesives-ltd) JYOTIRES · basing · Evidence leans down · 74% evidence 43.7 out of 100 Growth Capital Valuation Relative
14. [Foseco India Ltd](https://www.sectoralpha.in/stocks/foseco-india-ltd) FOSECOIND · leader · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
15. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) SGRL · breaking out · Evidence leans down · 85% evidence 40.3 out of 100 Growth Capital Valuation Relative
16. Oriental Aromatics Ltd this page OAL · leader · Evidence leans down · 74% evidence 36.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.0/35 · Revenue 13.5% · Profit -77.7% · Operating margin change -0.4 points · 88% evidence Capital efficiency 5.0/25 · ROCE 4.5% · Operating margin 7.6% · 100% evidence Valuation 8.0/20 · P/E 360× · PEG 1.5 · 65% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 70.3% · 1 year 55% · 25% evidence · 12 of 12 weeks ahead Exact sum: 11 + 5 + 8 + 12.5 = 36.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 17. [Gem Aromatics Ltd](https://www.sectoralpha.in/stocks/gem-aromatics-ltd) GEMAROMA · quiet · Too little evidence to rank firmly · 51% evidence 32.2 out of 100 Growth Capital Valuation Relative
18. [Sacheerome Ltd](https://www.sectoralpha.in/stocks/sacheerome-ltd) SACHEEROME · losing its lead · Too little evidence to rank firmly · 36% evidence 58.1 out of 100 Growth Capital Valuation Relative
19. [Shri Ahimsa Naturals Ltd](https://www.sectoralpha.in/stocks/shri-ahimsa-naturals-ltd) SHRIAHIMSA · leader · Too little evidence to rank firmly · 47% evidence 56.8 out of 100 Growth Capital Valuation Relative
20. [Citurgia Biochemicals Ltd](https://www.sectoralpha.in/stocks/citurgia-biochemicals-ltd) CITURGIA · Too little evidence to rank firmly · 25% evidence 34.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Organic](https://www.sectoralpha.in/sectors/chemicals-organic), all 20 compared on one page. ## Which companies are close to Oriental Aromatics in size? Oriental Aromatics is the 7th largest of 20 Chemicals - Organic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Balaji Amines, Foseco India and Laxmi Organic Industries. Just below it: Nitta Gelatin India, Citurgia Biochemicals and Sigachi Industries. ### Chemicals - Organic companies close in size

1. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) ₹5,721 crore
2. [Foseco India Ltd](https://www.sectoralpha.in/stocks/foseco-india-ltd) ₹4,419 crore
3. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) ₹4,245 crore
4. Oriental Aromatics Ltd ₹1,916 crore
5. [Nitta Gelatin India Ltd](https://www.sectoralpha.in/stocks/nitta-gelatin-india-ltd) ₹1,489 crore
6. [Citurgia Biochemicals Ltd](https://www.sectoralpha.in/stocks/citurgia-biochemicals-ltd) ₹1,449 crore
7. [Sigachi Industries Ltd](https://www.sectoralpha.in/stocks/sigachi-industries-ltd) ₹1,007 crore

[All 20 Chemicals - Organic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-organic#all-companies)

### Companies close in size in other industries

1. [Gretex Corporate Services Ltd](https://www.sectoralpha.in/stocks/gretex-corporate-services-ltd) ₹1,919 crore · Finance & Investments - Others
2. [Panacea Biotec Ltd](https://www.sectoralpha.in/stocks/panacea-biotec-ltd) ₹1,919 crore · Pharma - Others
3. Oriental Aromatics Ltd ₹1,916 crore
4. [Aayush Art and Bullion Ltd](https://www.sectoralpha.in/stocks/aayush-art-and-bullion-ltd) ₹1,915 crore · Trading
5. [GHV Infra Projects Ltd](https://www.sectoralpha.in/stocks/ghv-infra-projects-ltd) ₹1,911 crore · Construction - Civil/Turnkey

## What else do people ask about Oriental Aromatics? ### What is Oriental Aromatics's share price today? Oriental Aromatics Ltd's share price is ₹560.05, +51.5% over the past year. The whole company is worth ₹1,886 Cr on the market. In the last 52 weeks it traded between ₹235 to ₹628; today it is 83% of the way up from the low, 38.7% above its 200-day average (as of 3 November 2026). ### What were Oriental Aromatics's latest quarterly results? Oriental Aromatics Ltd reported revenue of ₹260 Cr and net profit of ₹2.5 Cr for the Jun 2026 quarter. Revenue rose 15.2% and profit rose 402.0% compared with a year earlier. Earnings per share were ₹0.75. The operating margin was 7.6%, 0.4 percentage points lower than a year earlier (as of 3 November 2026). ### What is Oriental Aromatics's market cap? Oriental Aromatics Ltd's market capitalisation is ₹1,886 Cr at a share price of ₹560.05. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Oriental Aromatics performing? Oriental Aromatics Ltd's share price has been rising for 20 weeks. In its latest quarter, revenue rose 15.2% and profit rose 402.0% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 12 weeks running (as of 3 November 2026). ### Will Oriental Aromatics's share price go up? This page does not forecast Oriental Aromatics Ltd's share price. What it shows instead: the share price is ₹560.05, and it has been rising for 20 weeks. Its P/E of 354.3× is higher than 99% of its own last 8 years (as of 3 November 2026). ### Who owns Oriental Aromatics? Promoters own 74.2% of Oriental Aromatics Ltd, foreign institutions 0.0%, domestic institutions 0.0% and the public 25.8% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 3 November 2026). ### Where is Oriental Aromatics in its business cycle? Oriental Aromatics Ltd's FY26 operating margin was 7.0%, against a 10-year range of 6.0% to 22.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 7.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Oriental Aromatics story? The main question: the share price moved +51.5% in a year while yearly earnings per share moved −90.4%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Oriental Aromatics a stock worth studying right now? What the numbers show: Oriental Aromatics Ltd's share price has risen faster than its earnings: +51.5% in a year, against −90.4% for earnings per share. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Oriental Aromatics share price forecast for 2026? What management itself guided: Management set a near-term sales-growth trajectory of 10.0%-15.0% over the next one year. ## Lists

- Momentum stocks: https://www.sectoralpha.in/momentum-stocks-india

This is research, not advice. We’re not SEBI-registered.